# Sensient Technologies Corp: financial statements, quarterly

SXT · NYSE · CIK 310142 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sxt.md) · [Financials](/companies/sxt/financials.md) · [Filings](/companies/sxt/filings.md) · [Insiders](/companies/sxt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sxt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [349 d](/filings/0001140361-26-005311.md) | [385](/filings/0001140361-25-017482.md) | [404](/filings/0001140361-25-028777.md) | [393](/filings/0001140361-25-040284.md) | [376 d](/filings/0001140361-26-005311.md) | [392](/filings/0001140361-26-019060.md) | [414](/filings/0001140361-26-031094.md) | [412](/filings/0001140361-26-041259.md) | [393 d](/filings/0001140361-26-005311.md) | [436](/filings/0001140361-26-019060.md) | [462](/filings/0001140361-26-031094.md) | [456](/filings/0001140361-26-041259.md) |
| Cost of revenue | $m | [249 d](/filings/0001140361-26-005311.md) | [258](/filings/0001140361-25-017482.md) | [273](/filings/0001140361-25-028777.md) | [262](/filings/0001140361-25-040284.md) | [257 d](/filings/0001140361-26-005311.md) | [261](/filings/0001140361-26-019060.md) | [271](/filings/0001140361-26-031094.md) | [271](/filings/0001140361-26-041259.md) | [270 d](/filings/0001140361-26-005311.md) | [283](/filings/0001140361-26-019060.md) | [289](/filings/0001140361-26-031094.md) | [291](/filings/0001140361-26-041259.md) |
| Selling, general and administrative | $m | [91.8 d](/filings/0001140361-26-005311.md) | [77.1](/filings/0001140361-25-017482.md) | [81.1](/filings/0001140361-25-028777.md) | [79.9](/filings/0001140361-25-040284.md) | [77.4 d](/filings/0001140361-26-005311.md) | [78.2](/filings/0001140361-26-019060.md) | [85.1](/filings/0001140361-26-031094.md) | [83.6](/filings/0001140361-26-041259.md) | [85.2 d](/filings/0001140361-26-005311.md) | [86.0](/filings/0001140361-26-019060.md) | [96.1](/filings/0001140361-26-031094.md) | [92.5](/filings/0001140361-26-041259.md) |
| Operating income | $m | [8.1 d](/filings/0001140361-26-005311.md) | [49.4](/filings/0001140361-25-017482.md) | [49.7](/filings/0001140361-25-028777.md) | [50.5](/filings/0001140361-25-040284.md) | [42.0 d](/filings/0001140361-26-005311.md) | [53.5](/filings/0001140361-26-019060.md) | [57.7](/filings/0001140361-26-031094.md) | [57.7](/filings/0001140361-26-041259.md) | [38.2 d](/filings/0001140361-26-005311.md) | [66.7](/filings/0001140361-26-019060.md) | [76.7](/filings/0001140361-26-031094.md) | [72.4](/filings/0001140361-26-041259.md) |
| Interest expense | $m | [6.5 d](/filings/0001140361-26-005311.md) | [7.0](/filings/0001140361-25-017482.md) | [7.7](/filings/0001140361-25-028777.md) | [7.7](/filings/0001140361-25-040284.md) | [6.4 d](/filings/0001140361-26-005311.md) | [7.3](/filings/0001140361-26-019060.md) | [7.4](/filings/0001140361-26-031094.md) | [7.3](/filings/0001140361-26-041259.md) | [7.5 d](/filings/0001140361-26-005311.md) | [7.9](/filings/0001140361-26-019060.md) | [8.2](/filings/0001140361-26-031094.md) | [8.3](/filings/0001140361-26-041259.md) |
| Income tax | $m | [7.4 d](/filings/0001140361-26-005311.md) | [11.4](/filings/0001140361-25-017482.md) | [11.1](/filings/0001140361-25-028777.md) | [10.1](/filings/0001140361-25-040284.md) | [5.5 d](/filings/0001140361-26-005311.md) | [11.7](/filings/0001140361-26-019060.md) | [12.7](/filings/0001140361-26-031094.md) | [13.4](/filings/0001140361-26-041259.md) | [5.2 d](/filings/0001140361-26-005311.md) | [14.7](/filings/0001140361-26-019060.md) | [17.2](/filings/0001140361-26-031094.md) | [15.8](/filings/0001140361-26-041259.md) |
| Net income | $m | [(5.8) d](/filings/0001140361-26-005311.md) | [30.9](/filings/0001140361-25-017482.md) | [30.9](/filings/0001140361-25-028777.md) | [32.7](/filings/0001140361-25-040284.md) | [30.1 d](/filings/0001140361-26-005311.md) | [34.5](/filings/0001140361-26-019060.md) | [37.6](/filings/0001140361-26-031094.md) | [37.0](/filings/0001140361-26-041259.md) | [25.5 d](/filings/0001140361-26-005311.md) | [44.2](/filings/0001140361-26-019060.md) | [51.4](/filings/0001140361-26-031094.md) | [48.3](/filings/0001140361-26-041259.md) |
| Diluted EPS | $ per share | not reported | [0.73](/filings/0001140361-25-017482.md) | [0.73](/filings/0001140361-25-028777.md) | [0.77](/filings/0001140361-25-040284.md) | not reported | [0.81](/filings/0001140361-26-019060.md) | [0.88](/filings/0001140361-26-031094.md) | [0.87](/filings/0001140361-26-041259.md) | not reported | [1.04](/filings/0001140361-26-019060.md) | [1.20](/filings/0001140361-26-031094.md) | [1.13](/filings/0001140361-26-041259.md) |
| Basic EPS | $ per share | not reported | [0.73](/filings/0001140361-25-017482.md) | [0.73](/filings/0001140361-25-028777.md) | [0.78](/filings/0001140361-25-040284.md) | not reported | [0.82](/filings/0001140361-26-019060.md) | [0.89](/filings/0001140361-26-031094.md) | [0.87](/filings/0001140361-26-041259.md) | not reported | [1.04](/filings/0001140361-26-019060.md) | [1.21](/filings/0001140361-26-031094.md) | [1.14](/filings/0001140361-26-041259.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [28.9](/filings/0001140361-25-005084.md) | [25.4](/filings/0001140361-24-024653.md) | [30.3](/filings/0001140361-24-036129.md) | [37.0](/filings/0001140361-24-045212.md) | [26.6](/filings/0001140361-26-005311.md) | [32.6](/filings/0001140361-25-017482.md) | [56.7](/filings/0001140361-25-028777.md) | [42.7](/filings/0001140361-25-040284.md) | [36.5](/filings/0001140361-26-041259.md) | [38.5](/filings/0001140361-26-019060.md) | [31.0](/filings/0001140361-26-031094.md) | [42.6](/filings/0001140361-26-041259.md) |
| Current assets | $m | [937](/filings/0001140361-25-005084.md) | [943](/filings/0001140361-24-024653.md) | [944](/filings/0001140361-24-036129.md) | [959](/filings/0001140361-24-045212.md) | [962](/filings/0001140361-26-005311.md) | [1,000](/filings/0001140361-25-017482.md) | [1,066](/filings/0001140361-25-028777.md) | [1,073](/filings/0001140361-25-040284.md) | [1,081](/filings/0001140361-26-041259.md) | [1,122](/filings/0001140361-26-019060.md) | [1,184](/filings/0001140361-26-031094.md) | [1,283](/filings/0001140361-26-041259.md) |
| Total assets | $m | [2,015](/filings/0001140361-26-005311.md) | [2,006](/filings/0001140361-25-017482.md) | [1,995](/filings/0001140361-25-028777.md) | [2,043](/filings/0001140361-25-040284.md) | [2,024](/filings/0001140361-26-005311.md) | [2,093](/filings/0001140361-26-019060.md) | [2,205](/filings/0001140361-26-031094.md) | [2,210](/filings/0001140361-26-041259.md) | [2,244](/filings/0001140361-26-041259.md) | [2,288](/filings/0001140361-26-019060.md) | [2,371](/filings/0001140361-26-031094.md) | [2,476](/filings/0001140361-26-041259.md) |
| Current liabilities | $m | [236](/filings/0001140361-25-005084.md) | [219](/filings/0001140361-24-024653.md) | [227](/filings/0001140361-24-036129.md) | [256](/filings/0001140361-24-045212.md) | [271](/filings/0001140361-26-005311.md) | [231](/filings/0001140361-25-017482.md) | [251](/filings/0001140361-25-028777.md) | [234](/filings/0001140361-25-040284.md) | [264](/filings/0001140361-26-041259.md) | [224](/filings/0001140361-26-019060.md) | [270](/filings/0001140361-26-031094.md) | [323](/filings/0001140361-26-041259.md) |
| Long-term debt | $m | [645](/filings/0001140361-25-005084.md) | [644](/filings/0001140361-24-024653.md) | [635](/filings/0001140361-24-036129.md) | [626](/filings/0001140361-24-045212.md) | [614](/filings/0001140361-26-005311.md) | [683](/filings/0001140361-25-017482.md) | [710](/filings/0001140361-25-028777.md) | [711](/filings/0001140361-25-040284.md) | [709](/filings/0001140361-26-041259.md) | [768](/filings/0001140361-26-019060.md) | [763](/filings/0001140361-26-031094.md) | [790](/filings/0001140361-26-041259.md) |
| Current portion of debt | $m | [0.1](/filings/0001140361-25-005084.md) | [19.4](/filings/0001140361-24-024653.md) | [27.0](/filings/0001140361-24-036129.md) | [17.8](/filings/0001140361-24-045212.md) | [0.2](/filings/0001140361-26-005311.md) | [18.6](/filings/0001140361-25-017482.md) | [26.3](/filings/0001140361-25-028777.md) | [0.8](/filings/0001140361-25-040284.md) | [0.2](/filings/0001140361-26-005311.md) | [0.2](/filings/0001140361-26-019060.md) | [0.4](/filings/0001140361-26-031094.md) | [0.3](/filings/0001140361-26-041259.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,053](/filings/0001140361-25-040284.md) | [1,064](/filings/0001140361-25-028777.md) | [1,058](/filings/0001140361-25-040284.md) | [1,080](/filings/0001140361-25-040284.md) | [1,061](/filings/0001140361-26-041259.md) | [1,095](/filings/0001140361-26-031094.md) | [1,157](/filings/0001140361-26-041259.md) | [1,180](/filings/0001140361-26-041259.md) | [1,194](/filings/0001140361-26-041259.md) | [1,219](/filings/0001140361-26-031094.md) | [1,260](/filings/0001140361-26-041259.md) | [1,287](/filings/0001140361-26-041259.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.9 d](/filings/0001140361-26-005311.md) | [15.1](/filings/0001140361-25-017482.md) | [43.8 d](/filings/0001140361-25-028777.md) | [76.8 d](/filings/0001140361-25-040284.md) | [21.4 d](/filings/0001140361-26-005311.md) | [(9.0)](/filings/0001140361-26-019060.md) | [48.3 d](/filings/0001140361-26-031094.md) | [44.0 d](/filings/0001140361-26-041259.md) | [44.6 d](/filings/0001140361-26-005311.md) | [(13.6)](/filings/0001140361-26-019060.md) | [48.5 d](/filings/0001140361-26-031094.md) | [40.5 d](/filings/0001140361-26-041259.md) |
| Capital expenditure | $m | [20.2 d](/filings/0001140361-26-005311.md) | [11.0](/filings/0001140361-25-017482.md) | [11.8 d](/filings/0001140361-25-028777.md) | [13.2 d](/filings/0001140361-25-040284.md) | [23.1 d](/filings/0001140361-26-005311.md) | [16.9](/filings/0001140361-26-019060.md) | [21.2 d](/filings/0001140361-26-031094.md) | [19.8 d](/filings/0001140361-26-041259.md) | [31.6 d](/filings/0001140361-26-005311.md) | [28.7](/filings/0001140361-26-019060.md) | [38.8 d](/filings/0001140361-26-031094.md) | [38.3 d](/filings/0001140361-26-041259.md) |
| Dividends paid | $m | [17.3 d](/filings/0001140361-26-005311.md) | [17.3](/filings/0001140361-25-017482.md) | [17.4 d](/filings/0001140361-25-028777.md) | [17.3 d](/filings/0001140361-25-040284.md) | [17.4 d](/filings/0001140361-26-005311.md) | [17.4](/filings/0001140361-26-019060.md) | [17.3 d](/filings/0001140361-26-031094.md) | [17.5 d](/filings/0001140361-26-041259.md) | [17.4 d](/filings/0001140361-26-005311.md) | [17.4](/filings/0001140361-26-019060.md) | [17.4 d](/filings/0001140361-26-031094.md) | [17.4 d](/filings/0001140361-26-041259.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [42.3](/filings/0001140361-24-024653.md) | [42.2](/filings/0001140361-24-036129.md) | [42.2](/filings/0001140361-24-045212.md) | [42.3](/filings/0001140361-25-017482.md) | [42.4](/filings/0001140361-25-028777.md) | [42.4](/filings/0001140361-25-040284.md) | [42.5](/filings/0001140361-26-019060.md) | [42.6](/filings/0001140361-26-031094.md) | [42.7](/filings/0001140361-26-041259.md) | [42.7](/filings/0001140361-26-019060.md) | [42.8](/filings/0001140361-26-031094.md) | [42.8](/filings/0001140361-26-041259.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,561,738 at 2026-10-22, from the cover of the [10-Q filed 2026-10-30](/filings/0001140361-26-041259.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 13:09 ET. No prices; not investment advice.